Bioventix PLC (LON:BVXP)‘s stock had its “corporate” rating reissued by investment analysts at FinnCap in a research report issued to clients and investors on Friday. They currently have a GBX 1,450 ($18.07) price objective on the biotechnology company’s stock. FinnCap’s price objective indicates a potential downside of 6.45% from the company’s previous close. Shares of […]
